Key result
Antihypertensive therapy cuts stroke and cerebrovascular disease by ~50%, favoring lower SBP targets.
Why the study?
Hypertension is a major modifiable risk factor for cerebrovascular diseases and stroke, but optimal blood pressure targets for primary prevention remain debated.
Does antihypertensive therapy targeting lower systolic blood pressure reduce the incidence of stroke in patients with arterial hypertension?
Does antihypertensive therapy targeting lower systolic blood pressure reduce the incidence of stroke in patients with arterial hypertension?
Antihypertensive therapy significantly reduces stroke incidence, and targeting a lower systolic blood pressure (120 mmHg) appears preferable for stroke prevention and mortality reduction.
May support lower SBP targets for stroke prevention; leaves open need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
J Widimský (2015) conducted a review in Arterial hypertension. Antihypertensive therapy vs. Placebo or standard blood pressure control was evaluated. Antihypertensive drug therapy decreases the incidence of cerebrovascular diseases and stroke by 40-60%, with lower systolic blood pressure targets appearing preferable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: